Cipla’s step-down associate company gets regulatory update for intravenous tramadol

18 Dec 2020 Evaluate

Cipla’s step-down associate company Avenue Therapeutics has received an update from the US health regulator for its new drug application for intravenous (IV) tramadol. Avenue Therapeutics' IV tramadol is intended to treat patients in acute pain who require an opioid.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1311.75 -14.10 (-1.06%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×